Modeling of Hypervolemia in Pulmonary Circulation in Rats Changes the Structure of NO-Mediated Relaxation of Pulmonary Arteries

Bull Exp Biol Med. 2020 Jul;169(3):314-317. doi: 10.1007/s10517-020-04877-8. Epub 2020 Aug 3.

Abstract

We analyzed the contribution of soluble guanylate cyclase-dependent pathway into NO-mediated relaxation of pulmonary arteries under conditions of high pulmonary blood flow modeled by creation of carotid artery-jugular vein shunt in rats. Inhibitor of soluble guanylate cyclase suppressed NO-donor induced relaxation was lower in rats with shunt, but dilatation in response to phosphodiesterase V inhibitor did not differ in the sham-operated and shunt groups. Thus, the structure of NO-mediated vasodilatation of pulmonary arteries under conditions of hypervolemia of pulmonary circulation was shifted to soluble guanylate cyclase-independent pathways, whereas intracellular soluble guanylate cyclase-dependent mechanisms of dilatation were in general unchanged.

Keywords: carotid artery-jugular vein shunt; nitric oxide; pulmonary artery; soluble guanylate cyclase.

MeSH terms

  • Animals
  • Cyclic GMP / metabolism
  • Guanylate Cyclase / metabolism*
  • Nitric Oxide / metabolism*
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Pulmonary Artery / physiology*
  • Pulmonary Circulation / physiology*
  • Rats
  • Vasodilation

Substances

  • Phosphodiesterase 5 Inhibitors
  • Nitric Oxide
  • Guanylate Cyclase
  • Cyclic GMP